The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

File photo of the reactor at Chalk River, Ont.
File photo of the reactor at Chalk River, Ont.
(MDS Nordion)

Nordion sale gets final regulatory approval

The bid by an American company to take over iconic Canadian medical isotope maker Nordion Inc. has passed its final hurdle.

Industry Canada has now approved the deal, which will see Nordion sold for about $800-million (U.S.) to Sterigenics International Inc., an Illinois-based company that specializes in sterilization services for medical device makers, as well as pharmaceutical and food companies.